1. Thiosemicarbazones as Aedes aegypti larvicidal.
- Author
-
da Silva, João Bosco P., Navarro, Daniela Maria do A.F., da Silva, Aluizio G., Santos, Geanne K.N., Dutra, Kamilla A., Moreira, Diogo Rodrigo, Ramos, Mozart N., Espíndola, José Wanderlan P., de Oliveira, Ana Daura T., Brondani, Dalci José, Leite, Ana Cristina L., Hernandes, Marcelo Zaldini, Pereira, Valéria R.A., da Rocha, Lucas F., de Castro, Maria Carolina A.B., de Oliveira, Beatriz C., Lan, Que, and Jr.Merz, Kenneth M.
- Subjects
- *
DRUG synthesis , *THIOSEMICARBAZONES , *QSAR models , *AEDES aegypti , *MOSQUITO larvae , *YELLOW fever treatment , *THERAPEUTICS - Abstract
A set of aryl- and phenoxymethyl-(thio)semicarbazones were synthetized, characterized and biologically evaluated against the larvae of Aedes aegypti ( A. aegypti ), the vector responsible for diseases like Dengue and Yellow Fever. (Q)SAR studies were useful for predicting the activities of the compounds not included to create the QSAR model as well as to predict the features of a new compound with improved activity. Docking studies corroborated experimental evidence of AeSCP- 2 as a potential target able to explain the larvicidal properties of its compounds. The trend observed between the in silico Docking scores and the in vitro pLC50 (equals −log LC50, at molar concentration) data indicated that the highest larvicidal compounds, or the compounds with the highest values for pLC50, are usually those with the higher docking scores (i.e., greater in silico affinity for the AeSCP-2 target). Determination of cytotoxicity for these compounds in mammal cells demonstrated that the top larvicide compounds are non-toxic. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF